Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Nashville, Tennessee 37232


Purpose:

The purpose of this study is to learn more about why patients with diabetes have increased heart attacks, strokes and other illnesses due to blood clots causing blockage of a blood vessel. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on endothelial function and fibrinolytic balance in Type 2 DM. Our hypothesis is that hyperglycemia, rather than hyperinsulinemia, is responsible for the dysregulation of fibrinolytic balance in diabetics.


Study summary:

This study will test the hypothesis that hyperglycemia will impair, while hyperinsulinemia will improve endothelial function and vascular fibrinolytic balance in type 2 DM. As discussed above, their roles in the increased prevalence of thrombotic events occurring in diabetics have not been defined. More recent data supports insulin as profibrinolytic and hyperglycemia to cause endothelial dysfunction. Conclusive studies are lacking in diabetic subjects. Furthermore, preliminary data from this lab indicates that in non-diabetic controls, hyperglycemia results in a prothrombotic state by increasing plasma PAI-1 and reducing tPA levels. The proposed protocol will study the separate and combined effects of hyperglycemia and hyperinsulinemia on endothelial function and fibrinolytic balance in Type 2 DM.


Criteria:

Inclusion Criteria: - 16 ( 8 female/ 8 male) Type 2 diabetic patients age 18-60 yrs - 16 ( 8 female/ 8 male) Non-diabetic controls age and weight matched - Body mass index 25-52 kgm2 - Female volunteers of childbearing potential: negative HCG pregnancy test - Volunteers over 40 years old: normal baseline ECG - For those with type 2 diabetes: HBA1C 6.5-10% Exclusion Criteria: - Prior history of poor health: any current or prior disease condition that alters carbohydrate metabolism and prior cardiac events and/or evidence for cardiac disease - Uncontrolled hypertension - History of cerebrovascular incidents - Pregnancy - Subjects unable to give voluntary informed consent - Subjects with a recent medical illness - Subjects with known liver or kidney disease - Subjects on anticoagulant drugs, anemic, or with known bleeding diseases - Tobacco Use


NCT ID:

NCT00574665


Primary Contact:

Principal Investigator
Stephen N. Davis, MD
Vanderbilt University


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee 37232
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.